OBO_ID (LABEL):	CL_0000542 (lymphocyte)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1164414	5/2005	S24-PMC1164414	['the diagnosis was established in our central reference laboratory by morphological fab criteria and cytochemistry when at least 25% Lymphoblasts were present in the Bone Marrow, or when blasts were present in the Peripheral Blood.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 132, 'lymphoblasts'), ('UBERON_0002371', 'bone marrow', 165, 'bone marrow'), ('UBERON_0012101', 'perinatal stage', 213, 'peripheral blood')]
PMC2409299	5/2008	S25-PMC2409299	['overall, Lymphocyte subpopulation data were obtained from 453 (83%) of 545 possible samples.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 9, 'lymphocyte')]
PMC2409299	5/2008	S33-PMC2409299	['the geometric mean Cord Blood Lymphocyte and Leucocyte counts were both higher in wet season births compared to dry season births (p = 0.007 and p = 0.0014 for Lymphocyte and Leucocyte counts respectively).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CL_0000542', 'lymphocyte', 30, 'lymphocyte'), ('CL_0000738', 'leukocyte', 45, 'leucocyte'), ('CL_0000542', 'lymphocyte', 160, 'lymphocyte'), ('CL_0000738', 'leukocyte', 175, 'leucocyte')]
PMC2409299	5/2008	S34-PMC2409299	['the Postnatal Lymphocyte and Leucocyte counts were also higher in wet season births (p = 0.0031 and p = 0.0002 for Lymphocyte and Leucocyte counts respectively, for all ages combined).']	N/A	N/A	[('GO_0007567', 'parturition', 4, 'postnatal'), ('CL_0000542', 'lymphocyte', 14, 'lymphocyte'), ('CL_0000738', 'leukocyte', 29, 'leucocyte'), ('CL_0000542', 'lymphocyte', 115, 'lymphocyte'), ('CL_0000738', 'leukocyte', 130, 'leucocyte')]
PMC2409299	5/2008	S43-PMC2409299	['caption (table-wrap): table 1\n\ngeometric mean absolute and percentage Lymphocyte subpopulation counts at each age and overall, according to season of Birth (values adjusted for gender, Gestation, Birth weight and monoclonal Antibody source; overall values also adjusted for age at measurement).absolute counts (× 109/l)percentage countsweekdry season birthwet season birthp-valuedry season birthwet season birthp-valuecd3+ 02.302.530.4151.850.50.7083.574.350.02958.758.20.77164.105.260.01457.759.00.66523.323.720.2660.961.90.71all3.403.850.0157.156.20.47 Cd4+ 01.451.730.1735.033.80.6582.492.730.2640.837.00.017162.803.280.0539.137.40.34522.072.190.5538.436.70.27all2.262.410.1537.835.10.0017 Cd8+ 01.291.440.4427.227.70.8280.981.470.01116.319.00.055161.341.650.09318.718.70.97521.121.280.2220.921.60.60all1.161.420.000720.421.40.18 Cd19+ 00.780.730.6817.414.60.08481.881.940.7932.730.70.37161.972.500.03432.934.70.39521.501.510.9527.725.50.32all1.541.660.2327.525.90.12 Cd56+ 00.840.780.6819.116.00.1480.270.350.0954.85.40.34160.250.330.0284.14.50.38520.210.290.00523.94.70.036all0.330.420.00146.16.50.17 cd4/cd8 ratio 01.31.20.7082.51.90.018162.12.00.69521.81.70.32all1.91.60.013\n\nage-related changes\ngeometric mean absolute and percentage Lymphocyte counts were highest at 16 weeks and significantly lower at 52 weeks (p = 0.0056 and p ≤ 0.0001 respectively).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 70, 'lymphocyte'), ('GO_0007567', 'parturition', 150, 'birth'), ('GO_0007565', 'female pregnancy', 185, 'gestation'), ('GO_0007567', 'parturition', 196, 'birth'), ('GO_0042571', 'immunoglobulin complex, circulating', 224, 'antibody'), ('PR_000001204', 'C-C chemokine receptor type 8', 555, 'CD4'), ('PR_000005170', 'CD37 molecule', 693, 'CD8'), ('PR_000001309', 'CD70 molecule', 833, 'CD19'), ('PR_000001309', 'CD70 molecule', 971, 'CD56'), ('CL_0000542', 'lymphocyte', 1242, 'lymphocyte')]
PMC2409299	5/2008	S58-PMC2409299	['there were no other observed associations between any Lymphocyte subpopulation and concurrent Plasma zinc, Retinol or Vitamin C concentration.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 54, 'lymphocyte'), ('UBERON_0001969', 'blood plasma', 94, 'plasma'), ('CHEBI_26536', 'retinoic acid', 107, 'retinol'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin C')]
PMC2409299	5/2008	S82-PMC2409299	['we found no effect of Birth weight on total Leucocyte count, Lymphocyte or subpopulation counts.']	N/A	N/A	[('GO_0007567', 'parturition', 22, 'birth'), ('CL_0000738', 'leukocyte', 44, 'leucocyte'), ('CL_0000542', 'lymphocyte', 61, 'lymphocyte')]
PMC2409299	5/2008	S129-PMC2409299	['location of the Lymphocyte gate, and freedom from Monocyte contamination, were assessed using monoclonal Antibodies to cd14+ and Cd45+.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 16, 'lymphocyte'), ('CL_0000576', 'monocyte', 50, 'monocyte'), ('GO_0042571', 'immunoglobulin complex, circulating', 105, 'antibodies'), ('PR_000001309', 'CD70 molecule', 129, 'CD45')]
PMC2409299	5/2008	S131-PMC2409299	['absolute counts of each cell sub-population were calculated in relation to Whole Blood Lymphocyte counts, measured as full Blood count and White Cell differential on the same fresh Blood sample (celloscope 1260, analys instrument ab).']	N/A	N/A	[('UBERON_0000473', 'testis', 75, 'whole blood'), ('CL_0000542', 'lymphocyte', 87, 'lymphocyte'), ('UBERON_0000178', 'blood', 123, 'blood'), ('CL_0000448', 'white fat cell', 139, 'white cell'), ('UBERON_0000178', 'blood', 181, 'blood')]
PMC2409299	5/2008	S150-PMC2409299	['the outcome analyses at Birth and 52-weeks of age were performed twice: first on the complete data sets, and then on subsets of data that excluded Cord Blood samples below 90% Cd45+ cells in the Lymphocyte gate (n = 7), and 52-week samples below 92% (n = 8).']	N/A	N/A	[('GO_0007567', 'parturition', 24, 'birth'), ('UBERON_0009472', 'axilla', 147, 'cord blood'), ('PR_000001309', 'CD70 molecule', 176, 'CD45'), ('CL_0000542', 'lymphocyte', 195, 'lymphocyte')]
PMC2621211	12/2008	S92-PMC2621211	['similar results were obtained in Lymphocyte-Mononuclear Cells isolated from Spleen of hmd and lmd Animals [9].']	N/A	N/A	[('CL_0000542', 'lymphocyte', 33, 'lymphocyte ...'), ('CL_0000226', 'single nucleate cell', 44, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 44, 'mononuclear'), ('UBERON_0002106', 'spleen', 76, 'spleen'), ('NCBITaxon_33208', 'Metazoa', 98, 'animals')]
PMC2704503	6/2007	S21-PMC2704503	['Cerebrospinal Fluid (csf) studies, including cytology, gram stain, culture, cryptococcus Antigen, and stain for Acid-fast bacilli, were normal (protein = 32; Glucose = 69; Leukocytes = 2; 92% Lymphocytes; Red Blood Cells [Rbc] = 1).']	N/A	N/A	[('UBERON_0001359', 'cerebrospinal fluid', 0, 'Cerebrospinal fluid'), ('CHEBI_59132', 'antigen', 89, 'antigen'), ('CHEBI_37527', 'acid', 112, 'acid'), ('CHEBI_17234', 'glucose', 158, 'glucose'), ('CL_0000738', 'leukocyte', 172, 'leukocytes'), ('CL_0000542', 'lymphocyte', 192, 'lymphocytes'), ('CL_0000232', 'erythrocyte', 205, 'red blood cells'), ('UBERON_0000178', 'blood', 209, 'blood'), ('CL_0000232', 'erythrocyte', 222, 'RBC')]
PMC2780862	12/2009	S147-PMC2780862	['Nf -Κ B and Il-6 also represent Genes with altered Histone H3 lysine 9 dimethylation in Lymphocytes from patients with type 1 diabetes (105).']	N/A	N/A	[('GO_0071159', 'NF-kappaB complex', 0, 'NF -κ'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 0, 'NF -κ B'), ('PR_000001470', 'interleukin-28B', 12, 'IL-6'), ('SO_0000704', 'gene', 32, 'genes'), ('CHEBI_15358', 'histone', 51, 'histone'), ('PR_000027594', 'histone H3', 51, 'histone H3'), ('CL_0000542', 'lymphocyte', 88, 'lymphocytes')]
PMC2922376	8/2010	S79-PMC2922376	['this region corresponds to a portion of the much larger region of the Slc6A4 Promoter analyzed in Lympophoblast Cell lines that quantified 81 Cpg Sites by traditional Bisulfite sequencing[18].']	N/A	N/A	[('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 70, 'SLC6A4'), ('SO_0000167', 'promoter', 77, 'promoter'), ('CL_0000542', 'lymphocyte', 98, 'lympophoblast cell'), ('UBERON_0000087', 'inner cell mass', 98, 'lympophoblast'), ('SO_0000036', 'matrix_attachment_site', 142, 'CpG sites'), ('CHEBI_29874', 'bromine dioxide', 167, 'bisulfite')]
PMC3031146	1/2011	S3-PMC3031146	['using the illumina infinium Human methylation27 beadchip, we assessed maternal Gene-specific methylation in over 27,000 Cpg Sites from dna isolated from Peripheral Blood Lymphocytes.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 28, 'Human'), ('SO_0000704', 'gene', 79, 'gene'), ('SO_0000036', 'matrix_attachment_site', 120, 'CpG sites'), ('UBERON_0012101', 'perinatal stage', 153, 'peripheral blood'), ('CL_0000081', 'blood cell', 164, 'blood'), ('CL_0000542', 'lymphocyte', 170, 'lymphocytes')]
PMC3131279	7/2011	S54-PMC3131279	['one Gene, Lymphocyte Activation Gene-3, was among the most up-regulated Genes in all three generations.']	N/A	N/A	[('SO_0000704', 'gene', 4, 'gene'), ('CL_0000542', 'lymphocyte', 10, 'lymphocyte'), ('GO_0046649', 'lymphocyte activation', 10, 'lymphocyte activation'), ('PR_000009659', 'laminin subunit gamma-2', 10, 'lymphocyte activation gene-3'), ('SO_0000704', 'gene', 32, 'gene'), ('SO_0000704', 'gene', 72, 'genes')]
PMC3415261	7/2012	S55-PMC3415261	['to establish the Immune development in Rats after Birth, we have studied the appearance of Lymphocyte subsets in Spleen of newborn lewis Rats during Suckling by means of immunofluorescence and flow cytometry [24].']	N/A	N/A	[('GO_0007566', 'embryo implantation', 17, 'immune'), ('UBERON_0002405', 'immune system', 17, 'immune'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 39, 'rats'), ('GO_0007567', 'parturition', 50, 'birth'), ('CL_0000542', 'lymphocyte', 91, 'lymphocyte'), ('UBERON_0002106', 'spleen', 113, 'spleen'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 137, 'rats'), ('GO_0001967', 'suckling behavior', 149, 'suckling')]
PMC3415261	7/2012	S60-PMC3415261	['studies about phenotypical Lymphocyte composition performed by flow cytometry analysis of the Spleen Cell suspensions during the Rat Suckling period [24] have allowed two phases to be defined: early Neonatal Life (first half) and late Suckling Period (second half) (figure 1(a)).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 27, 'lymphocyte'), ('CL_0000541', 'melanoblast', 94, 'spleen cell'), ('UBERON_0002106', 'spleen', 94, 'spleen'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 129, 'rat'), ('GO_0001967', 'suckling behavior', 133, 'suckling'), ('UBERON_0007221', 'neonate stage', 199, 'neonatal life'), ('GO_0001967', 'suckling behavior', 235, 'suckling'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 235, 'suckling period')]
PMC3415261	7/2012	S62-PMC3415261	['in the second phase of the Suckling Period (i.e., 10–21 days), the number of Cd4+ and Cd8+ Cells increases, and Lymphocytes bearing cd3, Tcr Αβ , Cd5, and Cd2 Molecules appear in the Spleen (as can be seen in the T-Cell pattern offigure 1(a)) [24].']	N/A	N/A	[('GO_0001967', 'suckling behavior', 27, 'suckling'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 27, 'suckling period'), ('PR_000001204', 'C-C chemokine receptor type 8', 77, 'CD4'), ('PR_000005170', 'CD37 molecule', 86, 'CD8'), ('CL_0000573', 'retinal cone cell', 91, 'cells'), ('CL_0000542', 'lymphocyte', 112, 'lymphocytes'), ('PR_000016190', 'trichohyalin-like protein 1', 137, 'TCR αβ'), ('PR_000001204', 'C-C chemokine receptor type 8', 146, 'CD5'), ('PR_000001204', 'C-C chemokine receptor type 8', 155, 'CD2'), ('CHEBI_36357', 'polyatomic entity', 159, 'molecules'), ('UBERON_0002106', 'spleen', 183, 'spleen'), ('CL_0000084', 'T cell', 213, 'T-cell')]
PMC3415261	7/2012	S91-PMC3415261	['with regard to the Development Of Intraepithelial Lymphocytes (Iels), which are Lymphocytes found in the Epithelial Layer Of the Intestinal Mucosa, we have isolated and characterized by flow cytometry the iel pattern in Rat Small Intestine during Suckling (figure 2(a)) [30].']	N/A	N/A	[('GO_0002413', 'tolerance induction to tumor cell', 19, 'development of intraepithelial lymphocytes'), ('CL_0002496', 'intraepithelial lymphocyte', 34, 'intraepithelial lymphocytes'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 34, 'intraepithelial'), ('CL_0002082', 'type II cell of adrenal medulla', 63, 'IELs'), ('CL_0000542', 'lymphocyte', 80, 'lymphocytes'), ('UBERON_0013231', 'sebaceous gland of eyelid', 105, 'epithelial layer of ...'), ('UBERON_0001242', 'intestinal mucosa', 129, 'intestinal mucosa'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 220, 'rat'), ('UBERON_0002108', 'small intestine', 224, 'small intestine'), ('GO_0001967', 'suckling behavior', 247, 'suckling')]
PMC3415261	7/2012	S111-PMC3415261	['lp Lymphocyte (lpl) composition in newborn Rats is quite different from that in Adults (figure 2(b)).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 3, 'lymphocyte'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 43, 'rats'), ('UBERON_0007023', 'adult organism', 80, 'adults')]
PMC3415261	7/2012	S122-PMC3415261	['Cd4+ T lpls, the most predominant subset in Adult Rat Lp, is the last Lymphocyte population to expand and this occurs after weaning (figure 2(b)) [31].']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 0, 'CD4'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 5, 'T'), ('UBERON_0007023', 'adult organism', 44, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 50, 'rat'), ('UBERON_0004619', 'lumbar vertebra 3', 54, 'LP'), ('CL_0000542', 'lymphocyte', 70, 'lymphocyte')]
PMC3420688	5/2012	S20-PMC3420688	['due to the decreased Glycoprotein anchoring ability of the pnh cell, there is a decreased copy number of Cd58 (Lymphocyte Function-Associated Antigen 3-Ligand (Lfa3)) on the Red Cell.']	N/A	N/A	[('CHEBI_17089', 'glycoprotein', 21, 'glycoprotein'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 105, 'CD58'), ('CL_0000542', 'lymphocyte', 111, 'lymphocyte'), ('PR_000009659', 'laminin subunit gamma-2', 111, 'lymphocyte function-associated antigen 3-ligand'), ('CHEBI_59132', 'antigen', 142, 'antigen'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 160, 'LFA3'), ('CL_0000232', 'erythrocyte', 174, 'red cell')]
PMC3501517	11/2012	S124-PMC3501517	['minimal Bal Fluid Lymphocytes were observed in both vds and vdd Mice treated with Lps (0.04±0.06×104vs.']	N/A	N/A	[('UBERON_0006310', 'vitelline venous plexus', 8, 'BAL fluid'), ('CL_0000542', 'lymphocyte', 18, 'lymphocytes'), ('NCBITaxon_10088', 'Mus <genus>', 64, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 82, 'LPS')]
PMC3501517	11/2012	S148-PMC3501517	['0.84±0.37×105cells), or Lymphocytes (0.03±0.09×104vs.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 24, 'lymphocytes')]
PMC3513828	11/2012	S34-PMC3513828	['on the third hospital day, a Transjugular Liver biopsy was performed that showed intense, active, interface hepatitis (figures1(a)and1(b)) with Lymphocytes, Neutrophils, and scant Plasma Cells, Bile Ductular Proliferation, and massive Hepatocyte dropout.']	N/A	N/A	[('UBERON_0008605', 'tragicus muscle', 29, 'transjugular'), ('UBERON_0002107', 'liver', 42, 'liver'), ('CL_0000542', 'lymphocyte', 144, 'lymphocytes'), ('CL_0000775', 'neutrophil', 157, 'neutrophils'), ('CL_0000786', 'plasma cell', 180, 'plasma cells'), ('UBERON_0004058', 'biliary ductule', 194, 'bile ductular'), ('GO_0008283', 'cell proliferation', 208, 'proliferation'), ('CL_0000182', 'hepatocyte', 235, 'hepatocyte')]
PMC3527219	11/2012	S4-PMC3527219	['Cortisol, total protein, Immunoglobulins, Lymphocyte Proliferation, Immune Cell counts, and cytokines were assessed in the Blood of offspring at baseline and under challenging conditions (weaning; Lipopolysaccharide (Lps) administration).']	N/A	N/A	[('CHEBI_17650', 'cortisol', 0, 'Cortisol'), ('GO_0019814', 'immunoglobulin complex', 25, 'immunoglobulins'), ('CL_0000542', 'lymphocyte', 42, 'lymphocyte'), ('GO_0046651', 'lymphocyte proliferation', 42, 'lymphocyte proliferation'), ('CL_0000738', 'leukocyte', 68, 'immune cell'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0000178', 'blood', 123, 'blood'), ('CHEBI_16412', 'lipopolysaccharide', 197, 'lipopolysaccharide'), ('CHEBI_16412', 'lipopolysaccharide', 217, 'LPS')]
PMC3527219	11/2012	S6-PMC3527219	['Immunoglobulin concentrations were decreased in lp (Iga) and hp piglets (Igg, Igm and iga) on the first day of Life ( p \u2009<\u20090.05), whereas the number of Lymphocytes and Mitogen-induced Lymphocyte Proliferation of the Piglets were unaffected by the maternal diet.']	N/A	N/A	[('GO_0019815', 'B cell receptor complex', 0, 'Immunoglobulin'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 52, 'IgA'), ('GO_0071735', 'IgG immunoglobulin complex', 73, 'IgG'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 78, 'IgM'), ('UBERON_0000104', 'life cycle', 111, 'life'), ('CL_0000542', 'lymphocyte', 152, 'lymphocytes'), ('CHEBI_52290', 'mitogen', 168, 'mitogen'), ('CL_0000542', 'lymphocyte', 184, 'lymphocyte'), ('GO_0046651', 'lymphocyte proliferation', 184, 'lymphocyte proliferation'), ('NCBITaxon_33208', 'Metazoa', 216, 'piglets')]
PMC3527219	11/2012	S76-PMC3527219	['the Mitogens Concanavalin A (5 μg/ml; cona) and Lipopolysaccharide (10 μg/ml; Lps) were used in Lymphocyte Proliferation/viability assays as previously described [28].']	N/A	N/A	[('CHEBI_52290', 'mitogen', 4, 'mitogens'), ('CHEBI_69856', 'Cosmosporaside B', 13, 'Concanavalin A'), ('CHEBI_16412', 'lipopolysaccharide', 48, 'lipopolysaccharide'), ('CHEBI_16412', 'lipopolysaccharide', 78, 'LPS'), ('CL_0000542', 'lymphocyte', 96, 'lymphocyte'), ('GO_0008283', 'cell proliferation', 107, 'proliferation')]
PMC3527219	11/2012	S91-PMC3527219	['to estimate the specific binding of Mouse monoclonal Antibodies to Cell Surface Of Lymphocytes Mouse-Igg2B negative control-Fitc and Mouse-Igg2A negative control-rpe (serotec, oxford, uk) were used.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 36, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('GO_0009504', 'cell plate', 67, 'cell surface of ...'), ('CL_0000542', 'lymphocyte', 83, 'lymphocytes'), ('NCBITaxon_10088', 'Mus <genus>', 95, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 101, 'IgG2b'), ('CHEBI_37926', 'fluorescein isothiocyanate', 124, 'FITC'), ('NCBITaxon_10088', 'Mus <genus>', 133, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 139, 'IgG2a')]
PMC3527219	11/2012	S152-PMC3527219	['the Lymphocyte Proliferation in response to both Mitogens cona and Lps was not influenced by maternal diet and diet\u2009×\u2009sampling time interaction ( p \u2009>\u20090.21).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 4, 'lymphocyte'), ('GO_0046651', 'lymphocyte proliferation', 4, 'lymphocyte proliferation'), ('CHEBI_52290', 'mitogen', 49, 'mitogens'), ('CHEBI_16412', 'lipopolysaccharide', 67, 'LPS')]
PMC3553086	1/2013	S49-PMC3553086	['dark grey bars represent Lymphoid Cells, light grey bars Myeloid Cells and black bar whole Blood.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 25, 'lymphoid cells'), ('CL_0000763', 'myeloid cell', 57, 'myeloid cells'), ('UBERON_0000178', 'blood', 91, 'blood')]
PMC3578836	2/2013	S203-PMC3578836	['cells of the Immune System are generated by Hematopoetic Stem Cells (Hscs) which develop during Gestation and self-renew as they give rise to Myeloid and Lymphoid cell lineages[30].']	N/A	N/A	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 20, 'system'), ('CL_0000037', 'hematopoietic stem cell', 44, 'hematopoetic stem cells'), ('GO_0030097', 'hemopoiesis', 44, 'hematopoetic'), ('CL_0000745', 'retina horizontal cell', 69, 'hSCs'), ('GO_0007565', 'female pregnancy', 96, 'gestation'), ('CL_0000766', 'myeloid leukocyte', 142, 'myeloid ...'), ('CL_0000542', 'lymphocyte', 154, 'lymphoid')]
PMC3613945	2/2013	S269-PMC3613945	['in such disorders, 1,25(Oh)2D3Downregulates Expression of Thyrocyte-derived Human Leukocyte Antigen Class Ii Molecules193And inhibits secretion of proinflammatory cytokines and Lymphocyte Proliferation194.']	N/A	N/A	[('CHEBI_37983', 'sulfur-35 atom', 19, '1'), ('CHEBI_17996', 'chloride', 20, ','), ('CHEBI_78726', '25-azacoprostane', 21, '25(OH)2D3downregulates'), ('GO_0010467', 'gene expression', 44, 'expression'), ('CL_0000893', 'thymocyte', 58, 'thyrocyte'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'human'), ('CL_0000738', 'leukocyte', 82, 'leukocyte'), ('PR_000009670', 'La-related protein 4', 82, 'leukocyte antigen class II'), ('CHEBI_59132', 'antigen', 92, 'antigen'), ('CHEBI_51122', '4,4-difluoro-8-(4-iodophenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene', 109, 'molecules193and'), ('CL_0000542', 'lymphocyte', 177, 'lymphocyte'), ('GO_0030595', 'leukocyte chemotaxis', 177, 'lymphocyte proliferation194')]
PMC3728489	7/2013	S60-PMC3728489	['an early vulnerable window occurs when the Tissues are being seeded by precursors of Immune Cells and varies depending on the type of Immune Cell (e.g., 4–7 weeks for Myeloid-derived Cells and 8–18 weeks for Lymphoid Cells) (dietert and dietert,2008).']	N/A	N/A	[('UBERON_0000479', 'tissue', 43, 'tissues'), ('CL_0000738', 'leukocyte', 85, 'immune cells'), ('UBERON_0002405', 'immune system', 85, 'immune'), ('CL_0000738', 'leukocyte', 134, 'immune cell'), ('UBERON_0002405', 'immune system', 134, 'immune'), ('CL_0000763', 'myeloid cell', 167, 'myeloid- ... cells'), ('CL_0000542', 'lymphocyte', 208, 'lymphoid cells')]
PMC3728489	7/2013	S64-PMC3728489	['the Thymus is populated by Lymphoid Cells through the process of Lymphocyte Maturation and positive and negative selection (central tolerance) in Gestational week 8–18, with continuing expansion of population within the Thymus as Gestation proceeds (leibnitz,2005).']	N/A	N/A	[('UBERON_0002370', 'thymus', 4, 'thymus'), ('CL_0000542', 'lymphocyte', 27, 'lymphoid cells'), ('CL_0000542', 'lymphocyte', 65, 'lymphocyte'), ('GO_0046651', 'lymphocyte proliferation', 65, 'lymphocyte maturation'), ('GO_0007565', 'female pregnancy', 146, 'gestational'), ('UBERON_0002370', 'thymus', 220, 'thymus'), ('GO_0007565', 'female pregnancy', 230, 'gestation')]
PMC3728489	7/2013	S165-PMC3728489	['Vitamin D is a direct regulator of Antimicrobial Innate Immune Responses, can inhibit Lymphocyte Proliferation (wang et al.,2004) and promote development of Tregs (lemire et al.,1984).']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_65381', 'albizoside C', 35, 'antimicrobial'), ('GO_0007602', 'phototransduction', 35, 'antimicrobial'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 49, 'innate immune responses'), ('UBERON_0002405', 'immune system', 56, 'immune'), ('CL_0000542', 'lymphocyte', 86, 'lymphocyte'), ('GO_0008283', 'cell proliferation', 97, 'proliferation'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 157, 'Tregs')]
PMC3773919	9/2013	S96-PMC3773919	['these same three strains decreased Th2 Cytokines production such as Il-4 and Il-5 in Lymph Node Cell cultures.']	N/A	N/A	[('GO_0007296', 'vitellogenesis', 35, 'Th2 cytokines'), ('PR_000001470', 'interleukin-28B', 68, 'IL-4'), ('PR_000001470', 'interleukin-28B', 77, 'IL-5'), ('CL_0000542', 'lymphocyte', 85, 'lymph node cell'), ('UBERON_0000029', 'lymph node', 85, 'lymph node')]
PMC3773919	9/2013	S164-PMC3773919	['in a Murine ad model, treatment with this Probiotic Mixture significantly inhibited the clinical symptoms of ad progression by reducing Ige levels (total and specific Ige levels), infiltrated Lymphocytes and Granulocytes, and levels of ad-associated cytokines [81].']	N/A	N/A	[('NCBITaxon_39107', 'Murinae', 5, 'murine'), ('CHEBI_73033', 'pterocarpan', 42, 'probiotic'), ('CHEBI_60004', 'mixture', 52, 'mixture'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 136, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 167, 'IgE'), ('CL_0000542', 'lymphocyte', 192, 'lymphocytes'), ('CL_0000094', 'granulocyte', 208, 'granulocytes')]
PMC3812030	10/2013	S19-PMC3812030	['for example, the Hypomethylation Of Genomic Dna in Lymphocytes in Postmenopausal women is reversed by increasing dietary Folate[7].']	N/A	N/A	[('GO_0034976', 'response to endoplasmic reticulum stress', 17, 'hypomethylation of ... DNA'), ('SO_0001026', 'genome', 36, 'genomic'), ('CL_0000542', 'lymphocyte', 51, 'lymphocytes'), ('GO_0007595', 'lactation', 66, 'postmenopausal'), ('CHEBI_30863', '5-azaorotic acid', 121, 'folate')]
PMC4026129	1/2014	S76-PMC4026129	['no associations with Line-1 methylation.hossain et al., 2012 [50•]newborns from thailand (n\u2009=\u200971); in vitro exposure to Arsenite (Lymphoblasts)Arsenic in Cord Blood\u2009=\u20090.51-10.37\xa0μg/g; Toenail\u2009=\u2009nd-8.23; Hair\u2009=\u2009nd-0.38\xa0μg/g; in vitro short term: 0, 10, 20, 50\xa0μm Naaso2For 0, 2, 4, 8\xa0h; in vitro long term: 0, 0.5, 1\xa0μm Naaso2For 0, 2, 4, 6, 8\xa0weekscord Blood Lymphocytes; Lymphoblast Cell line rpmi1788global Dna Methylation was calculated by determination of total 5-Methyldeoxycytidine content via hplc-ms/ms and the Dna Methylation status of Line-1 using combined Bisulfite restriction analysis (cobra).']	N/A	N/A	[('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 21, 'LINE-1'), ('CHEBI_29866', 'arsenite(3-)', 120, 'arsenite'), ('CL_0000542', 'lymphocyte', 130, 'lymphoblasts'), ('CHEBI_85195', '9,10-epoxyoctadecanoate', 143, 'Arsenic'), ('UBERON_0002240', 'spinal cord', 154, 'cord'), ('UBERON_0000178', 'blood', 159, 'blood'), ('UBERON_0009567', 'nail of pedal digit', 184, 'toenail'), ('UBERON_0001037', 'strand of hair', 203, 'hair'), ('CHEBI_7492', 'nedocromil', 262, 'NaAsO2for'), ('CHEBI_7492', 'nedocromil', 319, 'NaAsO2for'), ('CL_0000081', 'blood cell', 353, 'blood lymphocytes'), ('UBERON_0000178', 'blood', 353, 'blood'), ('CL_0000453', 'Langerhans cell', 372, 'Lymphoblast cell'), ('GO_0006306', 'DNA methylation', 409, 'DNA methylation'), ('CHEBI_20598', '5-methoxycarbonylmethyluridine', 466, '5-methyldeoxycytidine'), ('GO_0006306', 'DNA methylation', 519, 'DNA methylation'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 545, 'LINE-1'), ('CHEBI_29874', 'bromine dioxide', 567, 'bisulfite')]
PMC4113768	7/2014	S222-PMC4113768	['Vitamin D supplementation increased total White Blood Cell count, Lymphocyte count, Neutrophil count, Rbc and rdw.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000738', 'leukocyte', 42, 'white blood cell'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CL_0000542', 'lymphocyte', 66, 'lymphocyte'), ('CL_0000775', 'neutrophil', 84, 'neutrophil'), ('CL_0000232', 'erythrocyte', 102, 'RBC')]
PMC4142706	7/2014	S29-PMC4142706	['they also used it to study sbs rejoining in x-irradiated Human Lymphocytes.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 57, 'human'), ('CL_0000542', 'lymphocyte', 63, 'lymphocytes')]
PMC4143239	8/2014	S78-PMC4143239	['fewer Lymphocytes in Thymus Cortex.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 6, 'lymphocytes'), ('UBERON_0002123', 'cortex of thymus', 21, 'thymus cortex')]
PMC4143239	8/2014	S93-PMC4143239	['Small-Intestinal biopsies showed thinning of the Mucosa[33]–[36], decrease in villous height[37]–[43], altered villous morphology[32][40][44]and infiltration of Lymphocytes[32][34]–[38].']	N/A	N/A	[('UBERON_0000055', 'vessel', 0, 'Small'), ('UBERON_0000160', 'intestine', 6, 'intestinal'), ('UBERON_0000344', 'mucosa', 49, 'mucosa'), ('CL_0000542', 'lymphocyte', 161, 'lymphocytes')]
PMC4143239	8/2014	S198-PMC4143239	['Lymphocytes in Blood\nfifty-eight articles reported either total numbers of Lymphocytes or Lymphocyte subsets in Blood ( table s11 ).']	N/A	N/A	[('CL_0000849', 'crypt olfactory receptor neuron', 0, 'Lymphocytes'), ('UBERON_0000178', 'blood', 15, 'blood'), ('CL_0000542', 'lymphocyte', 75, 'lymphocytes'), ('CL_0000542', 'lymphocyte', 90, 'lymphocyte'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC4143239	8/2014	S209-PMC4143239	['Lymphocyte Response to Pha Stimulation\nin healthy children, incubation of Lymphocytes with Pha results in T-Lymphocytes to Proliferate.']	N/A	N/A	[('CL_0000824', 'mature natural killer cell', 0, 'Lymphocyte'), ('GO_0006974', 'cellular response to DNA damage stimulus', 0, 'Lymphocyte response'), ('CHEBI_34926', 'Pitrazepin', 23, 'PHA'), ('GO_0048866', 'stem cell fate specification', 27, 'stimulation'), ('CL_0000542', 'lymphocyte', 74, 'lymphocytes'), ('CHEBI_34926', 'Pitrazepin', 91, 'PHA'), ('CL_0000084', 'T cell', 106, 'T-lymphocytes'), ('GO_0008283', 'cell proliferation', 123, 'proliferate')]
PMC4143239	8/2014	S210-PMC4143239	['seventeen out of 23 articles reported a reduced proliferative response to Pha in Lymphocytes of malnourished children[93][97]–[98][101][147][154][163][177][179][186]–[187][189]–[190][192][196][203][212]–[218].']	N/A	N/A	[('CHEBI_34926', 'Pitrazepin', 74, 'PHA'), ('CL_0000542', 'lymphocyte', 81, 'lymphocytes')]
PMC4143239	8/2014	S215-PMC4143239	['for malnourished children infected with hiv, it was hoped that re-nutrition alone could increase their level of cd4+ Lymphocytes.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 117, 'lymphocytes')]
PMC4143239	8/2014	S220-PMC4143239	['malnourished children were found to have fewer Effector T-Lymphocytes, identified as cells lacking the “naïve” markers Cd62L and Cd28[90], fewer Activated T-Lymphocytes, with the markers Cd69 and/or Cd25[212][222][223], and fewer Memory T-Lymphocytes identified by the marker Cd45Ro+[86].']	N/A	N/A	[('CHEBI_35224', 'effector', 47, 'effector'), ('CL_0000911', 'effector T cell', 47, 'effector T-lymphocytes'), ('PR_000001309', 'CD70 molecule', 119, 'CD62L'), ('PR_000001309', 'CD70 molecule', 129, 'CD28'), ('CL_0002627', 'mature astrocyte', 145, 'activated T'), ('CL_0000542', 'lymphocyte', 157, 'lymphocytes'), ('PR_000001309', 'CD70 molecule', 187, 'CD69'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 199, 'CD25'), ('CL_0000313', 'serous secreting cell', 230, 'memory'), ('GO_0007613', 'memory', 230, 'memory'), ('CL_0000084', 'T cell', 237, 'T-lymphocytes'), ('PR_000005170', 'CD37 molecule', 276, 'CD45RO')]
PMC4143239	8/2014	S386-PMC4143239	['caption (supplementary-material): table s11\n\narticles describing Lymphocyte subsets in children with malnutrition.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 65, 'lymphocyte')]
PMC4161853	8/2014	S15-PMC4161853	['additionally, the Spleen contains the largest single aggregate of lymphoid Tissue in the body, housing approximately one third of the total Circulating Lymphocytes, thus with a vast number of them migrating through the Spleen at any given time, surpassing the combined traffic of all Lymph Nodes in the body [6].']	N/A	N/A	[('UBERON_0002106', 'spleen', 18, 'spleen'), ('UBERON_0000479', 'tissue', 75, 'tissue'), ('CL_0000080', 'circulating cell', 140, 'circulating'), ('CL_0000542', 'lymphocyte', 152, 'lymphocytes'), ('UBERON_0002106', 'spleen', 219, 'spleen'), ('UBERON_0000029', 'lymph node', 284, 'lymph nodes')]
PMC4161944	9/2014	S22-PMC4161944	['in addition, there are multipotential progenitors that can give rise to Myeloid and Lymphoid Cells independent of the Yolk Sac (2–4).']	N/A	N/A	[('CL_0000766', 'myeloid leukocyte', 72, 'myeloid ...'), ('CL_0000542', 'lymphocyte', 84, 'lymphoid cells'), ('UBERON_0001040', 'yolk sac', 118, 'yolk sac')]
PMC4208652	6/2014	S106-PMC4208652	['(2008)* def6 differentially Expressed in Fdcp6 Homolog Dgke Diacylglycerol Kinase Epsilon 64 Kda Dleu7 deleted in Lymphocytic leukemiahammarsund et al.']	N/A	N/A	[('GO_0010467', 'gene expression', 28, 'expressed'), ('PR_000007411', 'F-box only protein 42', 41, 'FDCP6'), ('SO_0000853', 'homologous_region', 47, 'homolog'), ('PR_000006449', 'diacylglycerol kinase kappa', 55, 'DGKE'), ('CHEBI_18035', 'diglyceride', 60, 'Diacylglycerol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 60, 'Diacylglycerol kinase epsilon 64 kDa'), ('PR_000006480', 'type I iodothyronine deiodinase', 97, 'DLEU7'), ('CL_0000542', 'lymphocyte', 114, 'lymphocytic')]
PMC4251881	11/2014	S105-PMC4251881	['histopathology will show Eosinophilic spongiosis, subepidermal blister, dermal infiltrate of Eosinophils, and Lymphocytes.']	N/A	N/A	[('CL_0000771', 'eosinophil', 25, 'eosinophilic'), ('CL_0000771', 'eosinophil', 93, 'eosinophils'), ('CL_0000542', 'lymphocyte', 110, 'lymphocytes')]
PMC4263713	12/2014	S63-PMC4263713	['isolation of Lymphocytes from the Spleen and Mesenteric Lymph Nodes\nthe Spleen and Mlns Tissues were cut into pieces with surgical scissors.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 13, 'lymphocytes'), ('UBERON_0002106', 'spleen', 34, 'spleen'), ('UBERON_0002509', 'mesenteric lymph node', 45, 'mesenteric lymph nodes'), ('UBERON_0002106', 'spleen', 72, 'spleen'), ('UBERON_0001791', 'inner nuclear layer of retina', 83, 'MLNs'), ('UBERON_0000479', 'tissue', 88, 'tissues')]
PMC4263713	12/2014	S68-PMC4263713	['then, 2 ml of fbs was used to release single cells from the pps, and the cell suspension was carefully added to the surface of a Lymphocyte separation medium for Rats (tianjin haoyang biological manufacture co., china).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 129, 'lymphocyte'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 162, 'rats')]
PMC4263713	12/2014	S69-PMC4263713	['following centrifugation at 2,000 rpm for 15 min, the white flocculent substance on the interface between the fbs and the Lymphocyte separation medium was transferred to a clean tube using a pasteur pipette.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 122, 'lymphocyte')]
PMC4263713	12/2014	S70-PMC4263713	['the Lymphocyte suspension was washed twice and resuspended with 100 µl of pbs for flow cytometry.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 4, 'lymphocyte')]
PMC4263713	12/2014	S76-PMC4263713	['the pellet was resuspended with fbs, and the Lymphocytes were isolated using the Lymphocyte separation medium for Rats (tianjin haoyang biological manufacture co., china).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 45, 'lymphocytes'), ('CL_0000542', 'lymphocyte', 81, 'lymphocyte'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 114, 'rats')]
PMC4263713	12/2014	S77-PMC4263713	['the Lymphocytes were washed twice with pbs for flow cytometry analysis.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 4, 'lymphocytes')]
PMC4271720	12/2014	S202-PMC4271720	['sjögren’s syndrome\nsjögren’s syndrome (ss; sjs) is an Autoimmune disease characterized by the dysfunction of exocrine glands and Lymphocytic infiltrations, particularly the Labial (minor Salivary) and Lacrimal Glands which leads to the hallmark symptoms of ss—xerostomia (dry Mouth) and keratoconjunctivitis sicca (dry Eyes).']	N/A	N/A	[('UBERON_0001442', 'skeleton of manus', 54, 'autoimmune'), ('CL_0000542', 'lymphocyte', 129, 'lymphocytic'), ('UBERON_0004084', 'genital labium', 173, 'labial ...'), ('UBERON_0011765', 'jugular lymph sac', 187, 'salivary ...'), ('UBERON_3010604', 'cranial glands', 201, 'lacrimal glands'), ('UBERON_0000165', 'mouth', 276, 'mouth'), ('UBERON_0000970', 'eye', 319, 'eyes')]
PMC4271720	12/2014	S239-PMC4271720	['(2014)used chip to profile H3K9 Acetylation, H3K4 Trimethylation, and H3K9 Dimethylation in Blood Monocytes and Lymphocytes from diabetes patients.']	N/A	N/A	[('GO_0043973', 'histone H3-K4 acetylation', 27, 'H3K9 acetylation'), ('GO_0034729', 'histone H3-K79 methylation', 45, 'H3K4 trimethylation'), ('GO_0034971', 'histone H3-R17 methylation', 70, 'H3K9 dimethylation'), ('CL_0000081', 'blood cell', 92, 'blood monocytes'), ('UBERON_0000178', 'blood', 92, 'blood'), ('CL_0000542', 'lymphocyte', 112, 'lymphocytes')]
PMC4314531	11/2014	S81-PMC4314531	['within more differentiated cell subsets, acute hfd fetal Livers were comparatively enriched in both Lymphoid (cd3+/B220+) and Myeloid (Gr1+/ter119+) Cells, relative to controls (figure\xa01h–i).']	N/A	N/A	[('UBERON_0002107', 'liver', 57, 'livers'), ('CL_0000542', 'lymphocyte', 100, 'lymphoid ...'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 115, 'B220'), ('CL_0000766', 'myeloid leukocyte', 126, 'myeloid ...'), ('PR_000008220', 'GRB2-related adapter protein 2', 135, 'Gr1'), ('CL_0000573', 'retinal cone cell', 149, 'cells')]
PMC4354412	3/2015	S46-PMC4354412	['we therefore monitored the development of different Lymphocyte populations in the Piglets’ Jejunal Epithelium, as well as the Ileal Mesenteric Lymph Nodes (il Mln), and the Ileal peyer’S Patch (il pp).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 52, 'lymphocyte'), ('NCBITaxon_33208', 'Metazoa', 82, 'piglets'), ('UBERON_0001949', 'gingival epithelium', 91, 'jejunal epithelium'), ('UBERON_0007643', 'node of ligamentum arteriosum', 126, 'ileal mesenteric lymph nodes'), ('UBERON_0001463', 'manual digit 1', 159, 'MLN'), ('UBERON_0005625', 'tubotympanic recess lumen', 173, 'ileal ... ’s patch')]
PMC4354412	3/2015	S126-PMC4354412	['the percentage of Lymphocytes (Cd45+/Cd172A−) was small, below 3 in 94% of the Milk samples (data not shown).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 18, 'lymphocytes'), ('PR_000001309', 'CD70 molecule', 31, 'CD45'), ('PR_000001309', 'CD70 molecule', 37, 'CD172a'), ('UBERON_0001913', 'milk', 79, 'milk')]
PMC4354412	3/2015	S163-PMC4354412	['caption (fig): figure 6\n\npercentages of Cd4+Cd25Med T Cells from total Lymphocytes in the il Mln of the Piglets on day 12 in relation to the cd14 value of the attendant sow Milk measured on day 17 of Lactation .']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 40, 'CD4'), ('PR_000005174', 'CD5 molecule-like', 44, 'CD25med'), ('CL_0000084', 'T cell', 52, 'T cells'), ('CL_0000542', 'lymphocyte', 71, 'lymphocytes'), ('UBERON_0001463', 'manual digit 1', 93, 'MLN'), ('NCBITaxon_33208', 'Metazoa', 104, 'piglets'), ('UBERON_0001913', 'milk', 173, 'milk'), ('GO_0007595', 'lactation', 200, 'lactation')]
PMC4354412	3/2015	S192-PMC4354412	['these large, Mononuclear cd14+cells were morphologically clearly distinguishable from small, Mononuclear, Cd45+Lymphocytic Cells or small, Polymorphonuclear Granulocytes (figures4a–c; plots\u20092–7 in supplementary material).']	N/A	N/A	[('CL_0000100', 'motor neuron', 13, 'mononuclear'), ('GO_0031097', 'medial cortex', 13, 'mononuclear'), ('CL_0000100', 'motor neuron', 93, 'mononuclear ...'), ('GO_0031097', 'medial cortex', 93, 'mononuclear'), ('PR_000001309', 'CD70 molecule', 106, 'CD45'), ('CL_0000542', 'lymphocyte', 111, 'lymphocytic cells'), ('CL_0000567', 'polymodal nocireceptor', 139, 'polymorphonuclear'), ('CL_0000094', 'granulocyte', 157, 'granulocytes')]
PMC4448820	5/2015	S677-PMC4448820	['● in the Adaptive Immune System, Lymphocyte function is impaired by id because Proliferation requires the activity of iron-containing enzymes including ribonucleotide reductase.']	N/A	N/A	[('GO_0051866', 'general adaptation syndrome', 9, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 18, 'immune system'), ('CL_0000542', 'lymphocyte', 33, 'lymphocyte'), ('GO_0008283', 'cell proliferation', 79, 'proliferation')]
PMC4448820	5/2015	S1305-PMC4448820	['Leukocytosis is classified according to the component of wbcs that contribute to an increase in the total number of wbcs; types include increased Neutrophil count, Lymphocyte count, Monocyte count, Eosinophilic Granulocyte count, Basophilic Granulocyte count, or Blastocyte (immature) Cells.']	N/A	N/A	[('GO_0043062', 'extracellular structure organization', 0, 'Leukocytosis'), ('CL_0000775', 'neutrophil', 146, 'neutrophil'), ('CL_0000542', 'lymphocyte', 164, 'lymphocyte'), ('CL_0000576', 'monocyte', 182, 'monocyte'), ('CL_0000771', 'eosinophil', 198, 'eosinophilic granulocyte'), ('CL_0000767', 'basophil', 230, 'basophilic granulocyte'), ('CL_0000055', 'non-terminally differentiated cell', 263, 'blastocyte ... cells')]
PMC4488777	5/2015	S153-PMC4488777	['as described earlier [2], vd has a potent Immuno-Modulating activity towards Lymphocytes t and the Antigen-presenting cells.']	N/A	N/A	[('GO_0050900', 'leukocyte migration', 42, 'immuno-modulating'), ('CL_0000542', 'lymphocyte', 77, 'lymphocytes'), ('CHEBI_59132', 'antigen', 99, 'antigen')]
PMC4490503	6/2015	S113-PMC4490503	['Adipocytes synthesize substances with Chemotactic and adhesive properties such as Mcp-1 and vascular and Intracellular adhesion Molecules (Vcam, Icam), which enhance influx of Lymphocytes and Monocytes [15].']	N/A	N/A	[('CL_0000136', 'fat cell', 0, 'Adipocytes'), ('GO_0000090', 'mitotic anaphase', 38, 'chemotactic'), ('PR_000010439', 'myeloid leukemia factor 1', 82, 'MCP-1'), ('GO_0005622', 'intracellular anatomical structure', 105, 'intracellular'), ('CHEBI_36357', 'polyatomic entity', 128, 'molecules'), ('PR_000017279', 'testis-specific basic protein Y 1', 139, 'VCAM'), ('PR_000001868', 'interleukin-6 receptor subunit beta', 145, 'ICAM'), ('CL_0000542', 'lymphocyte', 176, 'lymphocytes'), ('CL_0000576', 'monocyte', 192, 'monocytes')]
PMC4661500	11/2014	S505-PMC4661500	['Proliferative Transition in Lymphocytes are Regulated by Trpm7[176].']	N/A	N/A	[('GO_0007538', 'primary sex determination', 0, 'Proliferative transition'), ('CL_0000542', 'lymphocyte', 28, 'lymphocytes'), ('GO_0065007', 'biological regulation', 44, 'regulated'), ('PR_000016670', 'Cdc42-interacting protein 4', 57, 'TRPM7')]
PMC4685088	12/2015	S29-PMC4685088	['cells Of the innate Immune System Secrete cytokines, which can prime Lymphocytes thereby Modulating Adaptive Immunity (13).']	N/A	N/A	[('CL_0000025', 'egg cell', 6, 'of ...'), ('GO_0007566', 'embryo implantation', 20, 'immune'), ('UBERON_0002405', 'immune system', 20, 'immune system'), ('GO_0046903', 'secretion', 34, 'secrete'), ('CL_0000542', 'lymphocyte', 69, 'lymphocytes'), ('GO_0065007', 'biological regulation', 89, 'modulating'), ('GO_0051866', 'general adaptation syndrome', 100, 'adaptive immunity')]
PMC4685088	12/2015	S30-PMC4685088	['exposure to a specific Antigen causes these primed Lymphocytes to have a more rapid and intense Immune Response (14,15).']	N/A	N/A	[('CHEBI_59132', 'antigen', 23, 'antigen'), ('CL_0000542', 'lymphocyte', 51, 'lymphocytes'), ('GO_0006955', 'immune response', 96, 'immune response'), ('UBERON_0002405', 'immune system', 96, 'immune')]
PMC4703052	1/2016	S53-PMC4703052	['with a diverse pool of T and B Lymphocytes in place, Antigenic exposures drive the maturation of acquired Immune defenses by binding to, and activating, specific Lymphocytes with matching receptors.']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 23, 'T ...'), ('CL_0000236', 'B cell', 29, 'B lymphocytes'), ('CHEBI_59132', 'antigen', 53, 'antigenic'), ('UBERON_0002405', 'immune system', 106, 'immune'), ('CL_0000542', 'lymphocyte', 162, 'lymphocytes')]
PMC4703052	1/2016	S54-PMC4703052	['selected Lymphocytes undergo mitosis, passing on their Genes to subsequent generations of daughter cells that share the same Antigenic specificity.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 9, 'lymphocytes'), ('SO_0000704', 'gene', 55, 'genes'), ('CHEBI_59132', 'antigen', 125, 'antigenic')]
PMC4703052	1/2016	S81-PMC4703052	['Lymphocytes, Phagocytic Cells) and soluble proteins (e.g.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 0, 'lymphocytes'), ('CL_0000234', 'phagocyte', 13, 'phagocytic cells'), ('GO_0006909', 'phagocytosis', 13, 'phagocytic')]
PMC4703052	1/2016	S95-PMC4703052	['for example, infants receiving a vaccine against bacterial meningitis mounted a primary response which included, on average, the production of 11 Memory B Cells per 106total Lymphocytes and 19.8 μg/ml Igg Antibodies, both specific to the Antigen in the vaccine [46].']	N/A	N/A	[('CL_0000313', 'serous secreting cell', 146, 'memory'), ('GO_0007613', 'memory', 146, 'memory B cells'), ('CL_0000236', 'B cell', 153, 'B cells'), ('CL_0000542', 'lymphocyte', 174, 'lymphocytes'), ('GO_0071735', 'IgG immunoglobulin complex', 201, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 205, 'antibodies'), ('CHEBI_59132', 'antigen', 238, 'antigen')]
PMC4703052	1/2016	S105-PMC4703052	['the increase in Memory B Lymphocytes from 11 to 40 per 106lymphocytes translates into a total of 72 500 additional Cells In Circulation, which represents only 0.0029% of the total Lymphocyte pool.']	N/A	N/A	[('GO_0007613', 'memory', 16, 'memory'), ('CL_0000236', 'B cell', 23, 'B lymphocytes'), ('CL_0000080', 'circulating cell', 115, 'cells in circulation'), ('CL_0000542', 'lymphocyte', 180, 'lymphocyte')]
PMC4703052	1/2016	S178-PMC4703052	['different Antigenic exposures across environments result in different Lymphocyte pools.']	N/A	N/A	[('CHEBI_59132', 'antigen', 10, 'antigenic'), ('CL_0000542', 'lymphocyte', 70, 'lymphocyte')]
PMC4752899	11/2015	S120-PMC4752899	['there was a significant difference in the change in White Blood Cell and Lymphocyte counts with women in the placebo group experiencing a greater increase from pre- to post-treatment.']	N/A	N/A	[('CL_0000738', 'leukocyte', 52, 'white blood cell'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CL_0000542', 'lymphocyte', 73, 'lymphocyte')]
PMC4820961	3/2016	S214-PMC4820961	['cell counts\nthe following subtypes of White Blood Cells were counted in Blood samples: Neutrophils, Lymphocytes, Monocytes, Eosinophils and Basophils56.']	N/A	N/A	[('CL_0000738', 'leukocyte', 38, 'white blood cells'), ('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CL_0000775', 'neutrophil', 87, 'neutrophils'), ('CL_0000542', 'lymphocyte', 100, 'lymphocytes'), ('CL_0000576', 'monocyte', 113, 'monocytes'), ('CL_0000771', 'eosinophil', 124, 'eosinophils'), ('CL_0000767', 'basophil', 140, 'basophils56')]
PMC4829940	5/2016	S13-PMC4829940	['25(Oh)D is activated in a second hydroxylation step, by 1α-hydroxylase (encoded by Cyp27B1 ), primarily in the Kidneys, but also in other Tissues Expressing Cyp27B1 including Lymphocytes[1],[2].']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000006101', 'cytochrome P450 1A1', 83, 'CYP27B1'), ('UBERON_0002113', 'kidney', 111, 'kidneys'), ('UBERON_0000479', 'tissue', 138, 'tissues'), ('GO_0010467', 'gene expression', 146, 'expressing'), ('PR_000006101', 'cytochrome P450 1A1', 157, 'CYP27B1'), ('CL_0000542', 'lymphocyte', 175, 'lymphocytes')]
PMC4896250	4/2016	S61-PMC4896250	['in the second part, we concentrated on the site of the inflammation, and determined the composition of Lymphocyte infiltration in Labial Salivary Gland (Lsg) biopsies with special emphasis on tfhcells.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 103, 'lymphocyte'), ('UBERON_0006330', 'anterior lingual gland', 130, 'labial salivary gland'), ('UBERON_0002048', 'lung', 153, 'LSG')]
PMC4896250	4/2016	S63-PMC4896250	['lsgs were graded based on the organizational level of Periductal Lymphocytic infiltrates.']	N/A	N/A	[('UBERON_0003697', 'abdominal wall', 54, 'periductal'), ('CL_0000542', 'lymphocyte', 65, 'lymphocytic')]
PMC4896250	4/2016	S1603-PMC4896250	['Airway infiltration of Eosinophils and Lymphocytes of Mice transferred with ss clones were effectively inhibited by the administration of Dex.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 0, 'Airway'), ('CL_0000771', 'eosinophil', 23, 'eosinophils'), ('CL_0000542', 'lymphocyte', 39, 'lymphocytes'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'mice'), ('CHEBI_4450', 'desmopressin', 138, 'DEX')]
PMC4896250	4/2016	S2108-PMC4896250	['total cells numbers, and percentages of Eosinophils and Lymphocytes in the Bronchoalveolar Lavage Fluid as markers for Allergic inflammation were significantly decreased in the offspring of dams Fed scgos/lcfos during Lactation.']	N/A	N/A	[('CL_0000771', 'eosinophil', 40, 'eosinophils'), ('CL_0000542', 'lymphocyte', 56, 'lymphocytes'), ('UBERON_0004212', 'glomerular capillary', 75, 'bronchoalveolar lavage fluid'), ('GO_0040011', 'locomotion', 119, 'allergic'), ('GO_0007631', 'feeding behavior', 195, 'fed'), ('GO_0007595', 'lactation', 218, 'lactation')]
PMC4896250	4/2016	S2364-PMC4896250	['Blood tests on admission showed hemoglobin 16.1 g/dl, total Leukocyte count 5265 /ul (Neutrophils 78.7%, Lymphocytes 11.2%, Eosinophils 4.9%), ast 47 iu/l, alt 49 iu/l, Serum Bilirubin 0.55 mg/dl, serum creatinine 0.91 mg/dl and Blood Glucose 95 mg/dl.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000738', 'leukocyte', 60, 'leukocyte'), ('CL_0000775', 'neutrophil', 86, 'neutrophils'), ('CL_0000542', 'lymphocyte', 105, 'lymphocytes'), ('CL_0000771', 'eosinophil', 124, 'eosinophils'), ('UBERON_0001977', 'blood serum', 169, 'serum'), ('CHEBI_16990', 'bilirubin IXalpha', 175, 'bilirubin'), ('UBERON_0000178', 'blood', 229, 'blood'), ('CHEBI_17234', 'glucose', 235, 'glucose')]
PMC4896250	4/2016	S2459-PMC4896250	['methods: a Lymphocyte Transformation test (ltt) and Ifnγ-elispot assay using atds were performed using Peripheral Blood Mononuclear Cells from the patient.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 11, 'lymphocyte'), ('GO_0001572', 'lactosylceramide biosynthetic process', 11, 'lymphocyte transformation'), ('PR_000008920', 'interferon alpha-7', 52, 'IFNγ'), ('CL_0000111', 'peripheral neuron', 103, 'peripheral blood'), ('UBERON_0012101', 'perinatal stage', 103, 'peripheral'), ('UBERON_0000178', 'blood', 114, 'blood'), ('CL_0000226', 'single nucleate cell', 120, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 120, 'mononuclear')]
PMC4896250	4/2016	S2939-PMC4896250	['Hur ko Mice had significant decreases in Lung Neutrophils, Lymphocytes, Eosinophils and Il-13.']	N/A	N/A	[('PR_000008840', 'huntingtin', 0, 'HuR'), ('NCBITaxon_10088', 'Mus <genus>', 7, 'mice'), ('UBERON_0002048', 'lung', 41, 'lung'), ('CL_0000775', 'neutrophil', 46, 'neutrophils'), ('CL_0000542', 'lymphocyte', 59, 'lymphocytes'), ('CL_0000771', 'eosinophil', 72, 'eosinophils'), ('PR_000001470', 'interleukin-28B', 88, 'IL-13')]
PMC4896250	4/2016	S3317-PMC4896250	['we also measure cytokines include Il-17, Il-4, Il-10, Ifn-Gamma released from Lymphocyte in Pulmonary Lymph Node.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 34, 'IL-17'), ('PR_000001470', 'interleukin-28B', 41, 'IL-4'), ('PR_000001470', 'interleukin-28B', 47, 'IL-10'), ('PR_000008916', 'interferon alpha-21', 54, 'IFN-gamma'), ('CL_0000542', 'lymphocyte', 78, 'lymphocyte'), ('UBERON_0002006', 'cortex of lymph node', 92, 'pulmonary lymph node')]
PMC4896250	4/2016	S3320-PMC4896250	['Il-17 released from Lymphocyte in Pulmonary Lymph Node was significantly decreased (p < 0.05).']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 0, 'IL-17'), ('CL_0000542', 'lymphocyte', 20, 'lymphocyte'), ('UBERON_0002006', 'cortex of lymph node', 34, 'pulmonary lymph node')]
PMC4896250	4/2016	S3379-PMC4896250	['Budesonide reduced the number of Lymphocytes and Eosinophils in the bal.']	N/A	N/A	[('CHEBI_3220', 'Bupropion hydrochloride', 0, 'Budesonide'), ('CL_0000542', 'lymphocyte', 33, 'lymphocytes'), ('CL_0000771', 'eosinophil', 49, 'eosinophils')]
PMC4896250	4/2016	S5177-PMC4896250	['a365 laboratory diagnostic of staphylococcal sensitization\n\nnatalya khramykhoverchenko\n\nsemey state medical university kazakhstan\nintroduction: for the diagnosis of staphylococcal sensitization widely used immunological reactions (reaction of leucocytolis – Rll, the reaction of the inhibition of Leucocytes Migration – riml, the reaction of blast transformation of Lymphocytes – rbtl etc.).']	N/A	N/A	[('PR_000013950', 'regulator of G-protein signaling 16', 258, 'RLL'), ('CL_0000738', 'leukocyte', 297, 'leucocytes'), ('GO_0050900', 'leukocyte migration', 297, 'leucocytes migration'), ('CL_0000542', 'lymphocyte', 366, 'lymphocytes')]
PMC4896250	4/2016	S5595-PMC4896250	['there were also significant changes of Airway hypersensitivity, th1 and th2 cytokine patterns, Lymphocyte Proliferations and Immunoglobulin Production between l. gasseri -treated and non-treated Mice.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 39, 'airway'), ('CL_0000542', 'lymphocyte', 95, 'lymphocyte'), ('GO_0046651', 'lymphocyte proliferation', 95, 'lymphocyte proliferations'), ('GO_0019814', 'immunoglobulin complex', 125, 'immunoglobulin'), ('GO_0007128', 'meiotic prophase I', 140, 'production'), ('NCBITaxon_10088', 'Mus <genus>', 195, 'mice')]
PMC4896250	4/2016	S6248-PMC4896250	['Genome-wide Snp genotyping of the patients was performed using Genomic dna from peripheral Blood Lymphocytes.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genome'), ('SO_0000694', 'SNP', 12, 'SNP'), ('SO_0001026', 'genome', 63, 'genomic'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CL_0000542', 'lymphocyte', 97, 'lymphocytes')]
PMC4896250	4/2016	S6330-PMC4896250	['therefore, open Lung biopsy was performed, and it showed diffuse Interstitial Lymphocyte infiltrate.']	N/A	N/A	[('UBERON_0002048', 'lung', 16, 'lung'), ('UBERON_0005169', 'interstitial tissue', 65, 'interstitial'), ('CL_0000542', 'lymphocyte', 78, 'lymphocyte')]
PMC4896250	4/2016	S6333-PMC4896250	['the total Lymphocyte count and Lymphocyte subset were normal.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 10, 'lymphocyte'), ('CL_0000542', 'lymphocyte', 31, 'lymphocyte')]
PMC4896250	4/2016	S6829-PMC4896250	['in previous experiments of Mice, a short-term exposure to staphylococcal enterotoxin b (seb) induced extensive inflammatory responses in Lungs, including Lymphocytes, Neutrophils and Eosinophils.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 27, 'mice'), ('UBERON_0002048', 'lung', 137, 'lungs'), ('CL_0000542', 'lymphocyte', 154, 'lymphocytes'), ('CL_0000775', 'neutrophil', 167, 'neutrophils'), ('CL_0000771', 'eosinophil', 183, 'eosinophils')]
PMC4896250	4/2016	S7628-PMC4896250	['Bal levels of Lymphocytes, Neutrophils and Eosinophils decreased significantly (p<0.01) in Mice receiving anti-Il-4Ra loaded nanocarriers.']	N/A	N/A	[('UBERON_0006378', 'strand of vibrissa hair', 0, 'BAL'), ('CL_0000542', 'lymphocyte', 14, 'lymphocytes'), ('CL_0000775', 'neutrophil', 27, 'neutrophils'), ('CL_0000771', 'eosinophil', 43, 'eosinophils'), ('NCBITaxon_10088', 'Mus <genus>', 91, 'mice'), ('PR_000001366', 'interleukin-11', 111, 'IL-4Ra')]
PMC4896250	4/2016	S8463-PMC4896250	['her laboratory tests showed the percentage of Lymphocytes ranged between 35.6 % - 66 %.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 46, 'lymphocytes')]
PMC4896250	4/2016	S8476-PMC4896250	['discussion\ncbc test result does not automatically include the value of total Lymphocytes; it included only the percentage of Lymphocytes.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 77, 'lymphocytes'), ('CL_0000542', 'lymphocyte', 125, 'lymphocytes')]
PMC4896250	4/2016	S9363-PMC4896250	['all patients under 60 months of age with da had Neutrophil-Lymphocyte count ratio (nlcr) below 6 (7 cases, 53,8%).']	N/A	N/A	[('CL_0000775', 'neutrophil', 48, 'neutrophil'), ('CL_0000542', 'lymphocyte', 59, 'lymphocyte')]
PMC4979151	8/2016	S2-PMC4979151	['in a subset of participants ( n \u2009=\u200980), Cord Blood Mononuclear Cells (cbmc) were cultured, non-adherent Lymphocytes were isolated to assess T Cell Cytokine Responses to Phytohemagglutinin (pha) and anti-cd3/anti-Cd28 (Icd3/Icd28), measured by multiplex assay.']	N/A	N/A	[('CL_0000752', 'cone retinal bipolar cell', 40, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('GO_0031097', 'medial cortex', 51, 'mononuclear'), ('CL_0000542', 'lymphocyte', 104, 'lymphocytes'), ('CL_0000084', 'T cell', 140, 'T cell'), ('GO_0001801', 'positive regulation of type IIb hypersensitivity', 147, 'cytokine responses'), ('CHEBI_52428', 'phenethicillin(1-)', 169, 'phytohemagglutinin'), ('PR_000001309', 'CD70 molecule', 212, 'CD28'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 218, 'iCD3'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 223, 'iCD28')]
PMC4979151	8/2016	S3-PMC4979151	['in 12 participants, Lymphocyte Gene Expression profiles were analyzed by pcr array.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 20, 'lymphocyte'), ('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene')]
PMC4979151	8/2016	S32-PMC4979151	['for analysis of Lymphocyte Activation pathways by pcr array method, we selected 6 participants from the vitd group and 6 from the placebo group based on availability of complete data and adequate cbmc counts.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 16, 'lymphocyte'), ('GO_0046649', 'lymphocyte activation', 16, 'lymphocyte activation')]
PMC4979151	8/2016	S36-PMC4979151	['Cord Blood collection, Plasma and non-adherent Lymphocyte isolation\nVenous Cord Blood was collected immediately after Delivery and transferred to the icddr,b laboratory in dhaka for same-day processing (within 2–18 h).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0001969', 'blood plasma', 23, 'plasma'), ('CL_0000542', 'lymphocyte', 47, 'lymphocyte'), ('UBERON_0005296', 'ovary sex cord', 68, 'Venous cord'), ('UBERON_0000178', 'blood', 80, 'blood'), ('GO_0007567', 'parturition', 118, 'delivery')]
PMC4979151	8/2016	S39-PMC4979151	['the non-adherent Lymphocytes, which consisted predominantly of 70–75\xa0% of T Lymphocyte (cd3), 20–23\xa0% of B Lymphocytes (Cd19) and 5–7\xa0% of Natural Killer Cells (cd16) were separated from adherent Monocytes (cd14) (10–15\xa0% in total cbmc), and cultured in presence of stimulants (T Cell Mitogen phytohemagglutinin (Pha) or agonistic Antibodies to T-Cell receptor).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 17, 'lymphocytes'), ('CL_0000084', 'T cell', 74, 'T lymphocyte'), ('CL_0000236', 'B cell', 105, 'B lymphocytes'), ('PR_000001309', 'CD70 molecule', 120, 'CD19'), ('CL_0000623', 'natural killer cell', 139, 'Natural killer cells'), ('CL_0000576', 'monocyte', 196, 'monocytes'), ('CL_0000084', 'T cell', 278, 'T cell'), ('CHEBI_52290', 'mitogen', 285, 'mitogen'), ('CHEBI_34926', 'Pitrazepin', 313, 'PHA'), ('GO_0042571', 'immunoglobulin complex, circulating', 331, 'antibodies'), ('CL_0000084', 'T cell', 345, 'T-cell'), ('GO_0005622', 'intracellular anatomical structure', 346, '-cell')]
PMC4979151	8/2016	S40-PMC4979151	['Stimulation Of Lymphocytes\nstimulation with anti-cd3 and anti-Cd28 Antibodies predominantly activates T Lymphocytes.']	N/A	N/A	[('GO_0016445', 'somatic diversification of immunoglobulins', 0, 'Stimulation of lymphocytes'), ('CL_0000542', 'lymphocyte', 15, 'lymphocytes'), ('PR_000001309', 'CD70 molecule', 62, 'CD28'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies'), ('CL_0000084', 'T cell', 102, 'T lymphocytes')]
PMC4979151	8/2016	S42-PMC4979151	['one fraction of Lymphocytes was stimulated with anti-Human Cd3E (purified Mouse monoclonal Igg1, clone ucht1; r&d systems, minneapolis, mn 55413, usa), plus anti-Human Cd28 (purified Mouse monoclonal Igg1, clone 37407) (Icd3/Icd28) 5\xa0μg/ml each), the 2nd fraction of Lymphocytes was stimulated with Pha (sigma (st louis, mo, usa; 5\xa0μg/ml), and the 3rd fraction of Lymphocytes was cultured as control (without any stimulation) in 96-well Tissue culture plates (nunc, roskilde, denmark) for 48\xa0h at 37\xa0°c in 5\xa0% Co2 incubator.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 16, 'lymphocytes'), ('NCBITaxon_9606', 'Homo sapiens', 53, 'human'), ('PR_000005169', 'CMRF35-like molecule 9', 59, 'CD3e'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 91, 'IgG1'), ('NCBITaxon_9606', 'Homo sapiens', 162, 'human'), ('PR_000001309', 'CD70 molecule', 168, 'CD28'), ('NCBITaxon_10088', 'Mus <genus>', 183, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 200, 'IgG1'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 220, 'iCD3'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 225, 'iCD28'), ('CL_0000542', 'lymphocyte', 267, 'lymphocytes'), ('CHEBI_34926', 'Pitrazepin', 299, 'PHA'), ('CL_0000542', 'lymphocyte', 364, 'lymphocytes'), ('UBERON_0000479', 'tissue', 437, 'tissue'), ('CHEBI_16526', 'carbon dioxide', 510, 'CO2')]
PMC4979151	8/2016	S43-PMC4979151	['after incubation, all of the culture supernatant from each fraction of Lymphocytes was collected and used for assessment of cytokine secretion by cytometric bead array (cba).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 71, 'lymphocytes')]
PMC4979151	8/2016	S44-PMC4979151	['after Pha stimulation the Stimulated Lymphocytes were harvested by centrifugation, stored in rnalater (qiagen gmbh, hilden, germany) for further use for evaluating T Lymphocyte Activation markers by pcr array.']	N/A	N/A	[('CHEBI_34926', 'Pitrazepin', 6, 'PHA'), ('CL_0002651', 'endothelial cell of venous sinus of spleen', 26, 'stimulated'), ('CL_0000542', 'lymphocyte', 37, 'lymphocytes'), ('CL_0000084', 'T cell', 164, 'T lymphocyte'), ('GO_0042110', 'T cell activation', 164, 'T lymphocyte activation')]
PMC4979151	8/2016	S45-PMC4979151	['assessment of cytokines in Lymphocyte supernatant\nthe Human th1/th2/th17 cytometric bead array (cba) kit (bd biosciences, san jose, ca) was used for measurement of cytokines in culture supernatant from Icd3/Icd28- and pha-stimulated Lymphocytes.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 27, 'lymphocyte'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'Human'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 202, 'iCD3'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 207, 'iCD28'), ('CL_0000542', 'lymphocyte', 233, 'lymphocytes')]
PMC4979151	8/2016	S49-PMC4979151	['data were expressed as ratio of cytokines in the stimulated Lymphocytes by unstimulated control Lymphocytes.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 60, 'lymphocytes'), ('CL_0000542', 'lymphocyte', 96, 'lymphocytes')]
PMC4979151	8/2016	S52-PMC4979151	['T and B Cell Activation pathway\nextractions of mrna from both pha-stimulated and Unstimulated Lymphocytes were performed using rneasy mini kit according to the manufacturer’s instructions (qiagen gmbh, hilden, germany).']	N/A	N/A	[('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 0, 'T ...'), ('GO_0050909', 'sensory perception of taste', 0, 'T ...'), ('CL_0000236', 'B cell', 6, 'B cell'), ('GO_0042113', 'B cell activation', 6, 'B cell activation'), ('GO_0048061', 'positive gravitaxis', 81, 'unstimulated'), ('CL_0000542', 'lymphocyte', 94, 'lymphocytes')]
PMC4979151	8/2016	S64-PMC4979151	['for each participant, Gene Expression data was obtained for unstimulated and pha-stimulated Lymphocytes within a group; direct comparison between vitd and placebo groups was not performed in the software provided by sabiosciences.']	N/A	N/A	[('GO_0010467', 'gene expression', 22, 'gene expression'), ('SO_0000704', 'gene', 22, 'gene'), ('CL_0000542', 'lymphocyte', 92, 'lymphocytes')]
PMC4979151	8/2016	S88-PMC4979151	['caption (table-wrap): table 2\n\nconcentration of 25(oh)d3in baseline and Cord Blood samples25(Oh)d3nmol/Lplacebo ( n \u2009=\u200940)vitd ( n \u2009=\u200940) p -valueabaseline45.6\u2009±\u200921.442.6\u2009±\u200917.20.495cord Blood36.8\u2009±\u200916.2101.2\u2009±\u200929.9<0.000stratification of 25(Oh)D3Baseline\u2003\u2009<\u20093011 (27.5\xa0%)12 (30.0\xa0%)\u200330–4914 (35.0\xa0%)18 (45.0\xa0%)\u200350–7510 (25.0\xa0%)7 (17.5\xa0%)\u2003\u2009≥\u2009765 (12.5\xa0%)3 (7.5\xa0%)Cord Blood\u2003\u2009<\u20093017 (42.5\xa0%)1 (2.5\xa0%)\u200330–4917 (42.5\xa0%)1 (2.5\xa0%)\u200350–753 (7.5\xa0%)3 (7.5\xa0%)\u2003\u2009≥\u2009763 (7.5\xa0%)35 (87.5\xa0%)\ndata expressed as means\u2009±\u2009standard deviations and or numbers with percentages in parentheses\naindependent sample t test was used to assess the comparison of Serum 25(Oh)D3Concentrations between the two groups\n\ncytokine concentrations in stimulated Cord Blood Lymphocytes\nin the stimulation experiments, concentrations of all cytokines except for Il-4 were above the lod.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 72, 'cord'), ('UBERON_0000178', 'blood', 77, 'blood'), ('CHEBI_51686', 'haematoxylin', 92, '(OH'), ('CHEBI_82475', '4-Hydroxyazobenzene', 103, 'LPlacebo'), ('UBERON_0001977', 'blood serum', 187, 'blood36'), ('CHEBI_78028', 'mitoguazone hydrochloride', 239, '25(OH)D3Baseline'), ('UBERON_0000948', 'heart', 363, 'Cord'), ('UBERON_0000178', 'blood', 368, 'blood'), ('UBERON_0001977', 'blood serum', 633, 'serum'), ('CHEBI_73735', 'gadoterate', 639, '25(OH)D3concentrations'), ('PR_000029413', 'putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32', 645, 'D3concentrations'), ('CL_0000107', 'autonomic neuron', 724, 'cord blood'), ('UBERON_0009472', 'axilla', 724, 'cord blood'), ('CL_0000542', 'lymphocyte', 735, 'lymphocytes'), ('PR_000001470', 'interleukin-28B', 822, 'IL-4')]
PMC4979151	8/2016	S96-PMC4979151	['Prenatal Vitamin D supplementation and T and B Cell Activation pathways\nwithin each intervention group, comparisons were made between Genes from unstimulated and Stimulated Lymphocytes.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 39, 'T ...'), ('GO_0050909', 'sensory perception of taste', 39, 'T ...'), ('CL_0000236', 'B cell', 45, 'B cell'), ('GO_0042113', 'B cell activation', 45, 'B cell activation'), ('SO_0000704', 'gene', 134, 'genes'), ('CL_0002651', 'endothelial cell of venous sinus of spleen', 162, 'stimulated'), ('CL_0000542', 'lymphocyte', 173, 'lymphocytes')]
PMC4979151	8/2016	S100-PMC4979151	['compared to unstimulated control Lymphocytes, Pha stimulation significantly down-regulated many C-C Chemokine receptors (Ccr1, Ccr2, Ccr3 and Ccr5), multiple toll-like receptors (tlrs)(Tlr1, Tlr2, Tlr4, Tlr6, Tlr9), Cxcr4, Clec7A (C-Type Lectin Domain Family 7, Member A), Socs5 (Suppressor Of Cytokine Signaling 55), Icoslg (Inducible T-Cell Co-Stimulator Ligand), Cd3D and Cd3G (subunits in cd3-T Cell receptor Complex), Cd8B (B Subunit On Cytotoxic T Cells), Cd81 (Expressed on T Lymphocytes), Tgf-Β, Ifngr1, Ifngr2 (receptors of ifn-γ), Hla-Dr, Nck1, Nck2, and Histone deacetylases (Hdac4-9) (fig.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 33, 'lymphocytes'), ('CHEBI_34926', 'Pitrazepin', 46, 'PHA'), ('PR_000004915', 'carbonic anhydrase 12', 96, 'C-C'), ('CHEBI_28969', 'N,N-dimethyltryptamine', 100, 'chemokine'), ('PR_000001204', 'C-C chemokine receptor type 8', 121, 'CCR1'), ('PR_000001204', 'C-C chemokine receptor type 8', 127, 'CCR2'), ('PR_000001204', 'C-C chemokine receptor type 8', 133, 'CCR3'), ('PR_000001204', 'C-C chemokine receptor type 8', 142, 'CCR5'), ('PR_000001155', 'Toll-like receptor 4', 185, 'TLR1'), ('PR_000001155', 'Toll-like receptor 4', 191, 'TLR2'), ('PR_000001155', 'Toll-like receptor 4', 197, 'TLR4'), ('PR_000001155', 'Toll-like receptor 4', 203, 'TLR6'), ('PR_000001155', 'Toll-like receptor 4', 209, 'TLR9'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 216, 'CXCR4'), ('PR_000005563', 'C-type lectin domain family 18 member C', 223, 'CLEC7A'), ('PR_000029352', 'centrosomal protein of 85 kDa', 231, 'C-type lectin domain family 7, member A'), ('SO_0000417', 'polypeptide_domain', 245, 'domain'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 273, 'SOCS5'), ('PR_000015319', 'snRNA-activating protein complex subunit 4', 280, 'Suppressor of cytokine signaling 55'), ('GO_0019221', 'cytokine-mediated signaling pathway', 294, 'cytokine signaling'), ('PR_000008898', 'immediate early response 3-interacting protein 1', 318, 'ICOSLG'), ('PR_000008893', 'isopentenyl-diphosphate Delta-isomerase 2', 326, 'Inducible T-cell co-stimulator ligand'), ('CL_0000084', 'T cell', 336, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 337, '-'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 366, 'CD3D'), ('PR_000005170', 'CD37 molecule', 375, 'CD3G'), ('CL_0000918', 'Tc2 cell', 397, 'T Cell'), ('GO_0032991', 'protein-containing complex', 413, 'complex'), ('PR_000005170', 'CD37 molecule', 423, 'CD8B'), ('PR_000002195', 'caspase-1-like protease', 429, 'B subunit on'), ('CL_0000910', 'cytotoxic T cell', 442, 'cytotoxic T cells'), ('GO_0043066', 'negative regulation of apoptotic process', 442, 'cytotoxic'), ('PR_000016001', 'T-box transcription factor T', 452, 'T'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 462, 'CD81'), ('GO_0010467', 'gene expression', 468, 'expressed'), ('CL_0000084', 'T cell', 481, 'T lymphocytes'), ('PR_000000046', 'TGF-beta', 497, 'TGF-β'), ('PR_000008920', 'interferon alpha-7', 504, 'IFNGR1'), ('PR_000008920', 'interferon alpha-7', 512, 'IFNGR2'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 541, 'HLA-DR'), ('PR_000011040', 'nuclear receptor coactivator 1', 549, 'NCK1'), ('PR_000011040', 'nuclear receptor coactivator 1', 555, 'NCK2'), ('CHEBI_15358', 'histone', 565, 'histone'), ('PR_000043452', 'core histone', 565, 'histone'), ('PR_000008488', 'histone deacetylase 9', 587, 'HDAC4')]
PMC4989298	8/2016	S255-PMC4989298	['the biological activities of Eicosanoids are varied: for example, Prostaglandin E2 (Pge2) acts on Blood Vessels, Airways, the Stomach, the Kidneys, Neutrophil function, Lymphocytes and pain receptors.']	N/A	N/A	[('CHEBI_36744', 'guaiane sesquiterpenoid', 29, 'eicosanoids'), ('CHEBI_15551', 'prostaglandin E2', 66, 'prostaglandin E2'), ('PR_000013393', 'proteasome activator complex subunit 2', 66, 'prostaglandin E2'), ('CHEBI_7998', 'Peptide(-Leu)', 84, 'PGE2'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 84, 'PGE2'), ('UBERON_0001981', 'blood vessel', 98, 'blood vessels'), ('UBERON_0001005', 'respiratory airway', 113, 'airways'), ('UBERON_0000945', 'stomach', 126, 'stomach'), ('UBERON_0002113', 'kidney', 139, 'kidneys'), ('CL_0000775', 'neutrophil', 148, 'neutrophil'), ('CL_0000542', 'lymphocyte', 169, 'lymphocytes')]
PMC5121137	11/2016	S26-PMC5121137	['laboratory tests on admission reported hemoglobin of 16.2, a White Blood Cell count of 12,500 with a differential count of 62.9% Lymphocytes, and 17.8% Neutrophils.']	N/A	N/A	[('CL_0000738', 'leukocyte', 61, 'white blood cell'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CL_0000542', 'lymphocyte', 129, 'lymphocytes'), ('CL_0000775', 'neutrophil', 152, 'neutrophils')]
PMC5121137	11/2016	S43-PMC5121137	['a Lymphocytic infiltrate was also present (fig.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 2, 'lymphocytic')]
PMC5153572	11/2016	S144-PMC5153572	['the hypothyroidism of these disease states results from inflammation secondary to infiltration of the Gland by Lymphocyte and Leucocytes.']	N/A	N/A	[('UBERON_0002530', 'gland', 102, 'gland'), ('CL_0000542', 'lymphocyte', 111, 'lymphocyte'), ('CL_0000738', 'leukocyte', 126, 'leucocytes')]
PMC5183755	12/2016	S127-PMC5183755	['there were no significant differences between nonexposed group and exposed group regarding other Lymphocyte subpopulations (fig.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 97, 'lymphocyte')]
PMC5183755	12/2016	S185-PMC5183755	["figure s2: non smoking and smoking mother's newborns Lymphocyte subpopulation of their Cord Blood samples data were analyzed and no significant difference were detected."]	N/A	N/A	[('CL_0000542', 'lymphocyte', 53, 'lymphocyte'), ('UBERON_0002240', 'spinal cord', 87, 'cord'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC5482199	2/2017	S23-PMC5482199	['T-Cells were purified by removing adherent Monocytes in plastic Tissue-culture dishes and filtering the non-adherent Lymphocyte fraction through two cycles of Nylon wool columns using an established protocol [27].']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T-cells'), ('CL_0000576', 'monocyte', 43, 'monocytes'), ('UBERON_0000479', 'tissue', 64, 'tissue'), ('CL_0000542', 'lymphocyte', 117, 'lymphocyte'), ('CHEBI_25614', 'nylons', 159, 'nylon')]
PMC5482199	2/2017	S48-PMC5482199	['responses of in vitro matured Cb T-Cells\nimmune Responses of in vitro maturated Human Neonatal T-Cells were induced by adding Pha and Pma and measuring Lymphocyte Proliferation by quantifying the uptake of tritiated thymidine (3H-tdr) and by the cytokine release in 72-h cultures [30].']	N/A	N/A	[('CL_0000103', 'bipolar neuron', 30, 'CB'), ('CL_0000084', 'T cell', 33, 'T-cells'), ('GO_0060033', 'anatomical structure regression', 48, 'responses'), ('NCBITaxon_9606', 'Homo sapiens', 80, 'human'), ('CL_0000540', 'neuron', 86, 'neonatal'), ('CL_0000084', 'T cell', 95, 'T-cells'), ('CHEBI_34926', 'Pitrazepin', 126, 'PHA'), ('CHEBI_34913', 'Phenbenzamine hydrochloride', 134, 'PMA'), ('CL_0000542', 'lymphocyte', 152, 'lymphocyte'), ('GO_0008283', 'cell proliferation', 163, 'proliferation'), ('CHEBI_29238', 'tritium atom', 227, '3H')]
PMC5482199	2/2017	S123-PMC5482199	['this process, characterized by the unequal apportioning of cellular contents of the parent T-Cell into the two daughter cells, enables Lymphocyte fates to diverge early in an Immune Response when T-Cells are first stimulated by accessory cells [49,50].']	N/A	N/A	[('CL_0000084', 'T cell', 91, 'T-cell'), ('CL_0000542', 'lymphocyte', 135, 'lymphocyte'), ('GO_0006955', 'immune response', 175, 'immune response'), ('UBERON_0002405', 'immune system', 175, 'immune'), ('CL_0000084', 'T cell', 196, 'T-cells')]
PMC5537520	8/2017	S72-PMC5537520	['Intercellular Adhesion Molecule-1 (Icam-1, Cd54) is a Cell Surface protein that is Expressed at very low levels on Pulmonary Endothelium, Lymphocytes and Macrophages.']	N/A	N/A	[('GO_0044302', 'dentate gyrus mossy fiber', 0, 'Intercellular adhesion molecule-1'), ('PR_000008988', 'interleukin-1 family member 5', 0, 'Intercellular adhesion molecule-1'), ('CHEBI_36357', 'polyatomic entity', 23, 'molecule'), ('GO_0031416', 'NatB complex', 35, 'ICAM-1'), ('PR_000001367', 'interleukin-12 receptor subunit beta-1', 35, 'ICAM-1'), ('PR_000001309', 'CD70 molecule', 43, 'CD54'), ('GO_0009986', 'cell surface', 54, 'cell surface'), ('GO_0010467', 'gene expression', 83, 'expressed'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 115, 'pulmonary endothelium'), ('CL_0000542', 'lymphocyte', 138, 'lymphocytes'), ('CL_0000235', 'macrophage', 154, 'macrophages')]
PMC5716389	9/2017	S60-PMC5716389	['one early vulnerable period is when Tissues are being seeded by precursors of Immune Cells (4–7\xa0weeks for Myeloid-derived cells and 8–18\xa0weeks for Lymphoid Cells) [45].']	N/A	N/A	[('UBERON_0000479', 'tissue', 36, 'tissues'), ('CL_0000738', 'leukocyte', 78, 'immune cells'), ('UBERON_0002405', 'immune system', 78, 'immune'), ('CL_0000763', 'myeloid cell', 106, 'myeloid'), ('CL_0000542', 'lymphocyte', 147, 'lymphoid cells')]
